Evidence map›Paper›PMID 37152080›Full record

ArticlePorto biomedical journal

Outbreak of KPC-producing

David Peres, Paulo Figueiredo, Paulo Andrade, Nuno Rocha-Pereira, Cláudia Carvalho, Rita Ferraz, Raquel Duro, Arnaldo Dias, Abel Gomes, Cláudia Pereira and 11 more

Open access · diamondAbstract read
In one paragraph

Article in Porto biomedical journal. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 2 institutions in 1 country.

David PeresInfection and Antimicrobial Resistance Prevention and Control Unit, Matosinhos Local Health Unit, Matosinhos, Portugal.ORCID https://orcid.org/0000-0002-5744-904X
Paulo FigueiredoInfection and Antimicrobial Resistance Prevention and Control Unit, Centro Hospitalar Universitário São João, Porto, Portugal.
Paulo AndradeInfection and Antimicrobial Resistance Prevention and Control Unit, Centro Hospitalar Universitário São João, Porto, Portugal.
Nuno Rocha-PereiraInfection and Antimicrobial Resistance Prevention and Control Unit, Centro Hospitalar Universitário São João, Porto, Portugal.
Cláudia CarvalhoInfection and Antimicrobial Resistance Prevention and Control Unit, Centro Hospitalar Universitário São João, Porto, Portugal.
Rita FerrazInfection and Antimicrobial Resistance Prevention and Control Unit, Centro Hospitalar Universitário São João, Porto, Portugal.
Raquel DuroInfection and Antimicrobial Resistance Prevention and Control Unit, Centro Hospitalar Universitário São João, Porto, Portugal.
Arnaldo DiasInfection and Antimicrobial Resistance Prevention and Control Unit, Centro Hospitalar Universitário São João, Porto, Portugal.
Abel GomesInfection and Antimicrobial Resistance Prevention and Control Unit, Centro Hospitalar Universitário São João, Porto, Portugal.
Cláudia PereiraInfection and Antimicrobial Resistance Prevention and Control Unit, Centro Hospitalar Universitário São João, Porto, Portugal.
Gisélia BragaInfection and Antimicrobial Resistance Prevention and Control Unit, Centro Hospitalar Universitário São João, Porto, Portugal.
Virginia PereiraVascular Surgery Department, Centro Hospitalar Universitário São João, Porto, Portugal.
Lino AzevedoMicrobiology Laboratory, Centro Hospitalar Universitário São João, Porto, Portugal.
Edgar MonizMicrobiology Laboratory, Centro Hospitalar Universitário São João, Porto, Portugal.
Manuela RibeiroMicrobiology Laboratory, Centro Hospitalar Universitário São João, Porto, Portugal.
Eugénia FerreiraNational Reference Laboratory of Antibiotic Resistances and Healthcare Associated Infections, National Institute of Health Doutor Ricardo Jorge, Lisbon, Portugal.
Vera ManageiroNational Reference Laboratory of Antibiotic Resistances and Healthcare Associated Infections, National Institute of Health Doutor Ricardo Jorge, Lisbon, Portugal.
José TeixeiraVascular Surgery Department, Centro Hospitalar Universitário São João, Porto, Portugal.
Tiago GuimarãesMicrobiology Laboratory, Centro Hospitalar Universitário São João, Porto, Portugal.
Manuela CaniçaNational Reference Laboratory of Antibiotic Resistances and Healthcare Associated Infections, National Institute of Health Doutor Ricardo Jorge, Lisbon, Portugal.
Carlos AlvesInfection and Antimicrobial Resistance Prevention and Control Unit, Centro Hospitalar Universitário São João, Porto, Portugal.
Hospital de São João · PTNational Institute of Health Dr. Ricardo Jorge · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: KPC-producing Methods: A case of KPC-Kp was considered to be a patient positive for KPC-Kp with strong epidemiological plausibility of having acquired this microorganism in the affected wards and/or with genetic relationship ≥92% between KPC-Kp isolates. Active surveillance cultures (ASCs) and real-time polymerase chain reaction were used for the detection of carbapenemase genes through rectal swab in a selected population. Molecular analysis was performed using pulsed-field gel electrophoresis at the National Reference Laboratory. Patient risk factors were collected from the electronic medical record system. Information regarding outbreak containment strategy was collected from the Infection Control Unit records. Results: Of the 16 cases, 11 (69%) were identified through active screening, representing 1.4% of the total 766 ASCs collected. The most frequent risk factors identified were previous admission (63%), antibiotic exposure in the past 6 months (50%), and immunodepression (44%). The length of stay until KPC-Kp detection was high (0-121 days, mean 35.6), as was the total length of stay (5-173 days, mean 56.6). Three patients (19%) were infected by KPC-Kp, 2 of whom died. One previously colonized patient died later because of KPC-Kp infection. Conclusions: Multifactorial strategy based on contact precautions (with patient and healthcare professional cohorts) and ASC, as well as Antibiotic Stewardship Program reinforcement, allowed to contain this KPC-Kp outbreak.

Indexed as

active surveillance culturesantimicrobial resistancecarbapenemase-producing Enterobacteriaceaecontact precautionsKPC-producing K pneumoniaeoutbreak

Identifiers

PMID37152080
PMCPMC10158887
OpenAlexW4310689838

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.